Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SigmaRoc - Forecasts raised 10%

February 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SRC
  • Price:
  • 56p
The shares have rallied sharply from lows below 40p after SigmaRoc’s trading update raised guidance for FY’22 and eps is “now expected to be c. 10% ahead of expectations.” Revenues for the 11 months ended 30 November were £498m, up 20% year-on-year  on a like-for-like basis with “Demand conditions evolving broadly as expected across market segments, albeit some customers will use the high energy prices and holiday period as an excuse to bring forward planned maintenance.   Cost pressures were managed through dynamic pricing, savings initiatives and performance improvement programmes. Results are due at the end of March 2023. Liberum has upgraded eps forecasts for the year just ended by 8% to 7.7p. For this year and n ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X